At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 323 enrolled
Drug / intervention
oral nicotine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Nicotine Mini Lozenge in Relief of Provoked Acute Craving
In Brief
A Phase 2 clinical trial evaluating oral nicotine and Placebo for Smoking Dependence and Smoking. Completed, enrolled 323 participants across 1 site.
Detailed Summary
Evaluation of the ability of a nicotine mini lozenge to provide early relief of craving for a cigarette in smokers
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Dependence, Smoking
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2011
Primary CompletionDec 2011
First PostedJan 2012
TodayJul 2026
First PostedJan 10, 2012
Enrollment StartSep 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 14.5 years ago
Interventions
oral nicotinedrug
oral nicotine replacement product
Placebodrug
no active